BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 9, 2007
View Archived Issues
SuperGen presents overview of preclinical pipeline
Read More
Targeting topoisomerase II with R-16 induces apoptosis and cell cycle arrest in tumor cell lines
Read More
Recent patents disclose novel anticancer compounds
Read More
Resveratrol analogue M-8 active against melanoma cells
Read More
BAY-65-5811 and doxorubicin synergistic against melanoma cells
Read More
Hepatitis E virus vaccine effective in phase II study
Read More
Novel agents for inflammatory disorders disclosed in recent patents
Read More
Recent Merck Frosst patent describes new treatment option for atherosclerosis
Read More
HanAll licenses Nautilus compounds for South Korea
Read More
MK-2048 shows in vitro activity against resistant HIV-1 mutants
Read More
ProNAi and Novosom collaborate on DNAi-based cancer therapeutics
Read More
Novartis extends research collaboration with Idera
Read More
New formulation of oral methylnaltrexone begins clinical testing
Read More
Avalon and Merck & Co. collaborate in cancer
Read More
Phosphagenics extends transdermal technology platform
Read More
Affectis and Mitsubishi extend research collaboration
Read More
ZymoGenetics updates plans for rhThrombin
Read More
Crucell to receive funding in development of AdVac-based TB vaccine
Read More
Acrux and Organon sign new agreement in women's health
Read More
Novel polyamine biosynthesis inhibitor shows potential to prevent HIV/SIV-related encephalitis
Read More
ABT-894 begins phase II study for ADHD
Read More
Genta and IDIS sign compassionate use agreement for Ganite and Genasense
Read More
Stemline Therapeutics in-licenses worldwide rights to SL-401
Read More
RVX-208 completes toxicology studies on way to IND filing
Read More
NeuroVax studied in new phase II trial for relapsing-remitting MS
Read More
New phase I/II trial studies Ferritarg P for Hodgkin's disease
Read More
Financing at Potentia to support AMD program
Read More
AS-1404 with carboplatin and paclitaxel shows good response rate in NSCLC
Read More